Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α

Sorafenib resistance is one of the main obstacles to the treatment of advanced/recurrent hepatocellular carcinoma (HCC). Here, sorafenib-resistant HCC cells and xenografts in nude mice were used as experimental models. A cohort of patients with advanced recurrent HCC who were receiving sorafenib the...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yongxin, Shan, Wenqi, Yang, Ye, Jin, Ming, Dai, Yi, Yang, Hanyu, Jiao, Ruonan, Xia, Yunwei, Liu, Qinqiang, Ju, Liang, Huang, Guangming, Zhang, Jianping, Yang, Lihua, Li, Lei, Li, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642098/
https://www.ncbi.nlm.nih.gov/pubmed/31341646
http://dx.doi.org/10.1038/s41420-019-0200-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642098/
https://www.ncbi.nlm.nih.gov/pubmed/31341646
http://dx.doi.org/10.1038/s41420-019-0200-8

Ejemplares similares